Literature DB >> 18159114

Mortality among persons with a history of kawasaki disease in Japan: mortality among males with cardiac sequelae is significantly higher than that of the general population.

Yosikazu Nakamura1, Eiko Aso, Mayumi Yashiro, Ritei Uehara, Makoto Watanabe, Izumi Oki, Hiroshi Yanagawa.   

Abstract

BACKGROUND: The long-term prognosis of those having a history of Kawasaki disease (KD) is still unknown. METHODS AND
RESULTS: Between July 1982 and December 1992, 52 collaborating hospitals collected data on all patients having a new definite diagnosis of KD. Patients were followed-up until December 31, 2004 or their death. Standardized mortality ratios (SMRs) were calculated based on the Japanese vital statistics data. Of 6,576 patients enrolled, 36 (27 males, 9 females) died and the SMR was 1.14. Despite the high SMRs during the acute phase, the mortality rate was not high after the acute phase for the entire group of patients. Although the SMR after the acute phase was 0.71 for those without cardiac sequelae, 10 males (but none of the females) with cardiac sequelae died during the observation period; and the SMR for the male group with cardiac sequelae was 2.55 (95% confidence interval: 1.23-4.70).
CONCLUSIONS: The mortality rate among males with cardiac sequelae because of KD was significantly higher in this cohort than in the general population. On the other hand, those for females with the sequelae and for both males and females without sequelae were not elevated.

Entities:  

Mesh:

Year:  2008        PMID: 18159114     DOI: 10.1253/circj.72.134

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  Difference in Risk Factors for Subtypes of Acute Cardiac Lesions Resulting from Kawasaki Disease.

Authors:  Maho Yamashita; Ryusuke Ae; Mayumi Yashiro; Yasuko Aoyama; Takashi Sano; Nobuko Makino; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2016-11-23       Impact factor: 1.655

2.  Kawasaki disease and the emerging coronary artery disease epidemic in India: is there a correlation?

Authors:  Surjit Singh; Roosy Aulakh; Tomisaku Kawasaki
Journal:  Indian J Pediatr       Date:  2013-09-27       Impact factor: 1.967

3.  Myocardial fibrosis after adrenergic stimulation as a long-term sequela in a mouse model of Kawasaki disease vasculitis.

Authors:  Harry H Matundan; Jon Sin; Magali Noval Rivas; Michael C Fishbein; Thomas J Lehman; Shuang Chen; Roberta A Gottlieb; Timothy R Crother; Masanori Abe; Moshe Arditi
Journal:  JCI Insight       Date:  2019-02-07

4.  Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.

Authors:  Jennifer J Y Lee; Brian M Feldman; Brian W McCrindle; Ping Li; Rae Sm Yeung; Jessica Widdifield
Journal:  Pediatr Res       Date:  2022-08-24       Impact factor: 3.953

Review 5.  When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood.

Authors:  John B Gordon; Andrew M Kahn; Jane C Burns
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

6.  Follow-up chest X-ray in patients with Kawasaki disease: the significance and clinical application of coronary artery macro-calcification.

Authors:  Chantale Lapierre; Audrey Bitsch; Ronald Guérin; Laurent Garel; Joaquim Miró; Nagib Dahdah
Journal:  Pediatr Cardiol       Date:  2009-09-26       Impact factor: 1.655

Review 7.  CMR in inflammatory vasculitis.

Authors:  Subha V Raman; Ashish Aneja; Wael N Jarjour
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-30       Impact factor: 5.364

Review 8.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

Review 9.  Management of Kawasaki disease.

Authors:  D Eleftheriou; M Levin; D Shingadia; R Tulloh; N J Klein; P A Brogan
Journal:  Arch Dis Child       Date:  2013-10-25       Impact factor: 3.791

10.  Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009.

Authors:  Yosikazu Nakamura; Eiko Aso; Mayumi Yashiro; Satoshi Tsuboi; Takao Kojo; Yasuko Aoyama; Kazuhiko Kotani; Ritei Uehara; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2013-09-14       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.